FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283171034> ?p ?o ?g. }

• W4283171034 endingPage "1706" @default.
• W4283171034 startingPage "1695" @default.
• W4283171034 abstract "Aim: To evaluate berberine solid lipid nanoparticles' efficacy against doxorubicin-induced cardiotoxicity. Background: Berberine (Ber) is cardioprotective, but its oral bioavailability is low and its effect in chemotherapy-induced cardiotoxicity has not been studied. Objective: Solid lipid nanoparticles (SLNs) of berberine chloride were prepared, characterized and evaluated in vitro against Doxorubicin induced cardiomyocyte injury. Methodology: Berberine loaded SLNs (Ber-SLNs) were synthesized using water-in-oil microemulsion technique with tripalmitin, Tween 80 and poloxamer 407. Ber-SLNs were evaluated for preventive effect against toxicity of Doxorubicin in H9c2 cells. The culture was pre-treated (24 h) with Ber (10 µM) and Ber-SLNs (1 and 10 µM) and exposed to 1 µM of Doxorubicin (Dox) was added for 3 h. The cell viability (LDH (Lactate dehydrogenase) assay and MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)), levels of Creatine kinase-MB (CK-MB), Nitrite, MDA (Malondialdehyde), ROS (Reactive oxygen species) generation and apoptotic DNA (Deoxyribonucleic acid) content were assessed. Results: Ber-SLNs had a mean particle size of 13.12±1.188 nm, zeta potential of -1.05 ± 0.08 mV, poly-dispersity index (PDI) of 0.317 ± 0.05 and entrapment efficiency of 50 ± 4.8%. Cell viability was 81  0.17% for Ber-SLNs (10 µM) and 73.22  0.83% for Ber (10 µM) treated cells in MTT assay. Percentage cytotoxicity calculated from LDH release was 58.91  0.54% after Dox, 40.3  1.3% with Ber (10 µM) and 40.7  1.3% with Ber-SLNs (1 µM) (p<0.001). Inflammation and oxidative stress markers were lower with Ber and Ber-SLNs. Attenuation of ROS generation and apoptosis of cardiomyocytes were noted on fluorescence microscopy. Conclusion: Ber loaded SLNs effectively prevented Doxorubicin-induced inflammation and oxidative stress in rat cardiomyocytes. The results demonstrate that microemulsion is a simple, cost-effective technique to prepare Ber-SLNs and may be considered as a drug delivery vehicle for berberine." @default.
• W4283171034 created "2022-06-21" @default.
• W4283171034 creator A5003316013 @default.
• W4283171034 creator A5026345341 @default.
• W4283171034 creator A5045304008 @default.
• W4283171034 creator A5051173946 @default.
• W4283171034 creator A5090897648 @default.
• W4283171034 date "2022-08-01" @default.
• W4283171034 modified "2023-10-02" @default.
• W4283171034 title "Solid Lipid Nanoformulation of Berberine Attenuates Doxorubicin Triggered in vitro Inflammation in H9c2 Rat Cardiomyocytes" @default.
• W4283171034 cites W1500491597 @default.
• W4283171034 cites W1968794732 @default.
• W4283171034 cites W1978024724 @default.
• W4283171034 cites W1986638516 @default.
• W4283171034 cites W1996003434 @default.
• W4283171034 cites W2033763211 @default.
• W4283171034 cites W2050036109 @default.
• W4283171034 cites W2051092344 @default.
• W4283171034 cites W2060111182 @default.
• W4283171034 cites W2062327187 @default.
• W4283171034 cites W2078963194 @default.
• W4283171034 cites W2088154315 @default.
• W4283171034 cites W2091732904 @default.
• W4283171034 cites W2106926141 @default.
• W4283171034 cites W2138551472 @default.
• W4283171034 cites W2162689981 @default.
• W4283171034 cites W2180467040 @default.
• W4283171034 cites W2560154781 @default.
• W4283171034 cites W2560593836 @default.
• W4283171034 cites W2581607863 @default.
• W4283171034 cites W2587769401 @default.
• W4283171034 cites W2736835353 @default.
• W4283171034 cites W2752187810 @default.
• W4283171034 cites W2774161211 @default.
• W4283171034 cites W2783983996 @default.
• W4283171034 cites W2789348608 @default.
• W4283171034 cites W2790121275 @default.
• W4283171034 cites W2791899502 @default.
• W4283171034 cites W2792549766 @default.
• W4283171034 cites W2796742479 @default.
• W4283171034 cites W2800400752 @default.
• W4283171034 cites W2809905192 @default.
• W4283171034 cites W2884318134 @default.
• W4283171034 cites W2888324175 @default.
• W4283171034 cites W2906311118 @default.
• W4283171034 cites W2910288321 @default.
• W4283171034 cites W2914574872 @default.
• W4283171034 cites W2922961022 @default.
• W4283171034 cites W2978447526 @default.
• W4283171034 cites W3018708948 @default.
• W4283171034 cites W3027002103 @default.
• W4283171034 cites W3041007687 @default.
• W4283171034 cites W3048450008 @default.
• W4283171034 cites W3095846463 @default.
• W4283171034 cites W3132733467 @default.
• W4283171034 cites W3136127882 @default.
• W4283171034 cites W977049049 @default.
• W4283171034 doi "https://doi.org/10.2174/1386207325666220617113744" @default.
• W4283171034 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35718970" @default.
• W4283171034 hasPublicationYear "2022" @default.
• W4283171034 type Work @default.
• W4283171034 citedByCount "3" @default.
• W4283171034 countsByYear W42831710342023 @default.
• W4283171034 crossrefType "journal-article" @default.
• W4283171034 hasAuthorship W4283171034A5003316013 @default.
• W4283171034 hasAuthorship W4283171034A5026345341 @default.
• W4283171034 hasAuthorship W4283171034A5045304008 @default.
• W4283171034 hasAuthorship W4283171034A5051173946 @default.
• W4283171034 hasAuthorship W4283171034A5090897648 @default.
• W4283171034 hasConcept C109316439 @default.
• W4283171034 hasConcept C141071460 @default.
• W4283171034 hasConcept C178790620 @default.
• W4283171034 hasConcept C181199279 @default.
• W4283171034 hasConcept C185592680 @default.
• W4283171034 hasConcept C190283241 @default.
• W4283171034 hasConcept C199529486 @default.
• W4283171034 hasConcept C202751555 @default.
• W4283171034 hasConcept C2776694085 @default.
• W4283171034 hasConcept C2777318727 @default.
• W4283171034 hasConcept C2779820397 @default.
• W4283171034 hasConcept C2780116568 @default.
• W4283171034 hasConcept C2780783641 @default.
• W4283171034 hasConcept C2781303535 @default.
• W4283171034 hasConcept C53227056 @default.
• W4283171034 hasConcept C55493867 @default.
• W4283171034 hasConcept C71924100 @default.
• W4283171034 hasConcept C98274493 @default.
• W4283171034 hasConceptScore W4283171034C109316439 @default.
• W4283171034 hasConceptScore W4283171034C141071460 @default.
• W4283171034 hasConceptScore W4283171034C178790620 @default.
• W4283171034 hasConceptScore W4283171034C181199279 @default.
• W4283171034 hasConceptScore W4283171034C185592680 @default.
• W4283171034 hasConceptScore W4283171034C190283241 @default.
• W4283171034 hasConceptScore W4283171034C199529486 @default.
• W4283171034 hasConceptScore W4283171034C202751555 @default.
• W4283171034 hasConceptScore W4283171034C2776694085 @default.
• W4283171034 hasConceptScore W4283171034C2777318727 @default.
• W4283171034 hasConceptScore W4283171034C2779820397 @default.

• next